LEADERMED
offers
A global pharmaceutical platform encompassing critical aspects of drug development.
IP creation, clinical efficacy testing, regulatory approval, manufacturing, marketing, sales and distribution.
A pipeline filled with potential new medications, including a new treatment for diabetes, to be offered in China and the Asia-Pacific region.
A FASTER PIPELINE
The LeaderMed team’s expertise allows them to advance and obtain regulatory approvals for new drugs in China and the Asia-Pacific region faster than what can be secured in the U.S. and Europe.
In the China and Asia-Pacific markets our team members have led over 60 trials for innovative drugs; co-founded a CRO; led over 10 successful NDAs; and commercialized over $3 billion in global drug sales and medical devices, benefitting patients in over 50 countries.
What we believe
What others are saying
A Live Webcast
The Founder and Chief Executive Officer of LeaderMed Group, Dr. Joanne Jiang will present at the 2022 Jefferies Healthcare Conference on Friday, 10 June 2022, at 8:30-8:55 AM in TRACK 1.
A live webcast of the presentation will be accessible at https://wsw.com/webcast/jeff240/lmg/1687200. A replay of the presentation will be archived on LeaderMed’s website.
For more information on the conference or to schedule a one-on-one meeting with LeaderMed’s management, please contact Jefferies or Dr. Jenny Yuan via email at jenny.yuan@leadermedgroup.com or phone at +1 (908) 552-9052.